Modus Therapeutics (private company)

See something wrong or missing? Let us know
Offices:Stockholm
Business model:B2B

Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 19.35M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Modus Therapeutics

Name Criteria
Sweden Aprea Therapeutics
60%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: HealthCap, Rosetta Capital
  • At least one other investor: Karolinska Development
  • Total raised in a similar range: 10M+ USD
Sweden Asarina Pharma
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Rosetta Capital
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
Sweden Pharmanest
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Praktikerinvest
  • At least one other investor: Östersjöstiftelsen
Ireland Priothera Limited
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
Ireland SynOx Therapeutics
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
Finland Forendo Pharma
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Karolinska Development
  • Total raised in a similar range: 10M+ USD
Sweden Gesynta Pharma
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Karolinska Development
  • Total raised in a similar range: 10M+ USD
Sweden Scint-X
40%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Praktikerinvest
Sweden Doctrin
38%
  • Similar verticals: Health services
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
Top